Cary Street Partners’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.12M Sell
48,604
-3,278
-6% -$594K 0.16% 150
2026
Q1
$7.63M Buy
51,882
+16,271
+46% +$2.64M 0.19% 128
2025
Q4
$6.94M Buy
35,611
+10,979
+45% +$2.61M 0.17% 135
2025
Q3
$6.93M Sell
24,632
-11,780
-32% -$3M 0.18% 136
2025
Q2
$7.96M Buy
36,412
+977
+3% +$158K 0.22% 105
2025
Q1
$4.95M Buy
35,435
+20,134
+132% +$3.28M 0.16% 149
2024
Q4
$2.55M Buy
+15,301
New +$2.72M 0.08% 236

Other funds holding ORCL

Cary Street Partners's ORCL Position: Q2 2026 in Review

Cary Street Partners reduced its Oracle (ORCL) stake by 6.3% in Q2 2026, selling an estimated $594K and leaving 48,604 shares worth $7.12M. The position accounts for 0.16% of the portfolio, ranked #150.

Cary Street Partners first reported a position in ORCL in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.96M in Q2 2025. 1,495 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Cary Street Partners held 48,604 shares of Oracle worth $7.12M as of Q2 2026.
  • Cary Street Partners sold 3,278 Oracle shares in Q2 2026, an estimated $594K.
  • Oracle made up 0.16% of Cary Street Partners's portfolio in Q2 2026, its #150 holding.
  • Cary Street Partners first reported a position in Oracle in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Oracle position peaked at $7.96M in Q2 2025.
  • 1,495 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.